Up a level |
(2019) Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-Alzheimer's agents. Bioorganic chemistry. pp. 559-568. ISSN 1090-2120
(2018) Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease. Bioorganic chemistry. pp. 223-234. ISSN 1090-2120
(2018) Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds. European journal of medicinal chemistry. pp. 600-614. ISSN 1768-3254
(2017) New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease. European journal of medicinal chemistry. pp. 280-289. ISSN 1768-3254
(2017) Facile synthesis and antiproliferative activity of 7H-benzo7,8chromeno2,3-dpyrimidin-8-amines. European Journal of Medicinal Chemistry. pp. 128-136.
(2016) Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX. European journal of medicinal chemistry. pp. 298-308. ISSN 1768-3254
(2016) Hetero-annulated coumarins as new AChE/BuChE inhibitors: synthesis and biological evaluation. Medicinal Chemistry Research. pp. 1831-1841.
(2016) Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents. Archiv der Pharmazie. pp. 293-301.
(2016) Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase. Journal of Enzyme Inhibition and Medicinal Chemistry. pp. 205-209.
(2016) Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety. European Journal of Medicinal Chemistry. pp. 40-46.
(2015) Synthesis and anticholinergic activity of 4-hydroxycoumarin derivatives containing substituted benzyl-1,2,3-triazole moiety. Chemical biology & drug design. pp. 1215-20. ISSN 1747-0285
(2015) Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors. European journal of medicinal chemistry. pp. 361-9. ISSN 1768-3254
(2015) Design, synthesis and anticholinesterase activity of novel benzylidenechroman-4-ones bearing cyclic amine side chain. European journal of medicinal chemistry. pp. 181-9. ISSN 1768-3254
(2015) Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors. European journal of medicinal chemistry. pp. 196-201. ISSN 1768-3254
(2015) 9H-Carbazole Derivatives Containing the N-Benzyl-1,2,3-triazole Moiety as New Acetylcholinesterase Inhibitors. Archiv der Pharmazie. pp. 366-374.
(2015) New tetracyclic tacrine analogs containing pyrano2,3-cpyrazole: Efficient synthesis, biological assessment and docking simulation study. European Journal of Medicinal Chemistry. pp. 296-303.
(2015) Synthesis and biological evaluation of 5-benzylidenerhodanine-3-acetic acid derivatives as AChE and 15-LOX inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. pp. 389-395.
(2014) Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives. European journal of medicinal chemistry. pp. 536-44. ISSN 1768-3254
(2014) Imidazo2,1-bthiazole derivatives as new inhibitors of 15-lipoxygenase. European Journal of Medicinal Chemistry. pp. 759-764.
(2014) Indolinone-based acetylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling. European Journal of Medicinal Chemistry. pp. 375-381.
(2014) Synthesis, biological evaluation and docking study of 3-aroyl-1-(4- sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors. European Journal of Medicinal Chemistry. pp. 308-313.
(2013) 5-Nitro-heteroarylidene analogs of 2-thiazolylimino-4-thiazolidinones as a novel series of antibacterial agents. Medicinal Chemistry Research. pp. 2293-2302.
(2013) Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. European Journal of Medicinal Chemistry. pp. 252-259.